Clinical trials
Completed Hyperoxaluria, Primary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 4 |
| Mayo Clinic | 4 |
| Alnylam Pharmaceuticals | 3 |
| OxThera | 3 |
| Allena Pharmaceuticals | 1 |
| NYU Langone Health | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperoxaluria, Primary | 17 |
| Hyperoxaluria | 8 |
| Kidney Calculi | 2 |
| Cystinuria | 1 |
| Dent Disease | 1 |
| Genetic Diseases, Inborn | 1 |
| Kidney Diseases | 1 |
| Nephrocalcinosis | 1 |
| Urologic Diseases | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.